MLL-PTD as a marker for minimal residual disease studies: quantification counts
- PMID: 15996915
MLL-PTD as a marker for minimal residual disease studies: quantification counts
Comment on
-
Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy.Haematologica. 2005 Jul;90(7):881-9. Haematologica. 2005. PMID: 15996925
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical